Ledger.Open graph →
SEC Form D · Amendment · filed January 8, 2025

Luminary Therapeutics, Inc

Offering
$5.5M
Sold
$5.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minneapolis, MN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James Haymaker · Minneapolis, MNDirector · PromoterMark Chance · Minneapolis, MNDirectorTracey Lodie · Minneapolis, MNDirectorJeff Liter · Minneapolis, MNExec · Director · PromoterJohn Wells · Minneapolis, MNDirectorJeff Ross · Minneapolis, MNDirectorC. R. Carter · Atlanta, GADirectorDouglas E. Mark · MINNEAPOLIS, MNExec · Director · PromoterJeff Ross · Minneapolis, MNDirectorMichael Falk · West Palm Beach, FLDirector · PromoterBenjamin A. Lincoln · Santa Monica, CADirectorJason Gelberd · West Palm Beach, FLDirectorMichael Aceti · Needham, MADirectorDean Eliott · Needham, MADirectorSteven J. Speck, Ii · BOWLING GREEN, OHExec · Director · PromoterEvan Zemsky · New York, NYDirectorMark S. Feldman · Dallas, TXDirector · PromoterDavid R. Johnson · Rio Rancho, NMDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗